Journal of Oxygen Compounds

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Oxygen Compounds-Investigate p53 signaling and particularly to dissect the interactions of p53 family members with other upstream regulatory proteins-Ying Hu

China

Professor,
Harbin Institute of Technology.

0086-13354519232

Send an Email

Ying Hu

Address:

Professor, Harbin Institute of Technology.

Research Interests:

Investigate p53 signaling and particularly to dissect the interactions of p53 family members with other upstream regulatory proteins, such as ASPPs.

Biography:

  • Dr. Ying Hu, Ph.D.in cancer biology, now is a Professor of biology, PI of the Gene function Research Laboratory in the School of Life Science of Technology, Harbin Institute of Technology. 
  • She got his B. Sc in public health and then finished her Maser degree majoring in biochemistry and molecular biology. After that she finished her PhD training in cancer biology in the University College London. 
  • Dr. Hu worked in the University of Oxford for about 2 years for as a postdoctoral scientist before she went back to China and set up her own research team in 2012. 
  • Dr. Hu’s research interest is to investigate p53 signaling and particularly to dissect the interactions of p53 family members with other upstream regulatory proteins, such as ASPPs. 
  • Her group is focused on the translational and posttranslational regulatory mechanisms of ASPPs. Another paradigm of their work is to reveal p53-independent biological functions of ASPPs. 
  • The research in the lab is carried out at molecular and cellular levels using both cancer cells models and clinical human cancer tissue samples. 
  • The methods and technologies used in her current lab include in vitro cell culture, MTT, Western Blotting, FACS, RT-PCR, molecular cloning, soft agar assay and many other molecular and cellular tools. 
  • The goal of laboratory is to develop clinically relevant biomarkers and therapeutic targets for human malignancy diseases.